Midatech Pharma Plc Enters Into An Agreement For The Purchase In A Registered Direct Offering

  • Oct 23, 2019 BST
  • Team Kalkine
  • Midatech Pharma Plc (MTPH) has entered into a definitive binding agreement with an institutional investor for the purchase in a registered direct offering of 3 million of its ADSs (American Depositary Shares).
  • Each ADS is equivalent to 20 of the Company's ordinary shares and the purchase price is of USD1.00 per ADS, for aggregate gross proceeds of USD3.0 million. The offering is expected to close on or about 25 October 2019
  • The company also agreed to issue to the Investor unregistered warrants to purchase up to 3 million ADSs.
  • On 23rd October 2019, at the time of writing, GMT 09:38 AM, MTPH shares were trading at GBX 4.90, down by 0.70 points or 12.50 per cent against the previous day closing price.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK